Quanticate is a leading global biometric Contract Research Organisation (CRO) specializing in clinical data analysis for the pharma and biotech industries. They provide a range of services focused on enhancing clinical trial efficiency and success, including biostatistics, clinical data management, medical writing, and pharmacovigilance. Quanticate leverages advanced methodologies, such as Bayesian approaches, to optimize trial execution and data standardization, ensuring compliance with regulatory standards. They offer scalable resources tailored to client needs and have expertise across various therapeutic areas and trial phases, from early Phase I to post-marketing Phase IV trials. Quanticate is known for its robust data automation, visualisation, and analytics capabilities, which support decision-making and regulatory submissions.